FindTrial
Sign In

HEV Seroprevalence, Serum and Stool HEV RNA Positivity in Post Liver Transplant Patients During 1-Year Follow Up Period

HEV Seroprevalence, Serum and Stool HEV RNA Positivity in Post Liver Transplant Patients During 1-Year Follow Up Period

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20170112005
Enrollment
89
Registered
2017-01-12
Start date
2015-10-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HEV seroprevalence in Post liver transplant patients Serum and Stool HEV RNA detection in Post liver transplant during 1&#45

Interventions

Post liver transplant patients in transplant clinic of King Chulalongkorn Memorial Hospital
Screening
Post liver transplant patients

Sponsors

The Gastroenterological Association of Thailand
Lead Sponsor
The Gastroenterological Association of Thailand
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Post liver transplant patients Willing to take blood collect and stool sample

Exclusion criteria

Exclusion criteria: Unwilling patients

Design outcomes

Primary

MeasureTime frame
HEV seroprevalence 1 year Serology by ELISA—

Secondary

MeasureTime frame
HEV RNA detection in serum and stool 1 year RNA detection by RT-PCR—

Countries

Thailand

Contacts

Public ContactVinita Oranrap

Division of Gastroenterology, King Chulalongkorn Memorial Hospital

vinita.ying@hotmail.com66875903837

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026